<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00289367</url>
  </required_header>
  <id_info>
    <org_study_id>05-075</org_study_id>
    <nct_id>NCT00289367</nct_id>
  </id_info>
  <brief_title>Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery</brief_title>
  <official_title>Randomized Prospective Study of T3 on the Incidence of Post-Operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Thomas and Jeanne Elmezzi Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Northwell Health</source>
  <brief_summary>
    <textblock>
      The purpose of this project is to see whether treatment with a thyroid hormone, called
      triiodothyronine or T3, following open heart surgery reduces the risk of developing atrial
      fibrillation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2006</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">August 2006</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of atrial fibrillation</measure>
    <time_frame>during hospitalization</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Atrial Fibrillation</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triiodothyronine</intervention_name>
    <description>0.8 mcg/kg bolus loading dose followed by a six hour infusion of 0.8 mcg/kg/6hr.</description>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>triiodothyronine</intervention_name>
    <description>IV formulation - Triostat, 0.8 mcg/kg bolus loading dose followed by a six hour infusion of 0.8 mcg/kg/6hr.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients requiring CABG or valve repair/replacement surgery.

          2. Patient must be able to provide informed consent.

        Exclusion Criteria:

          1. Patients less than 18 or over 85 years of age.

          2. Patients less than 50kg or greater than 120kg.

          3. Patients currently with endocrine disorders, excluding diabetes.

          4. Patients currently with thyroid dysfunction (e.g., hyper- hyperthyroidism, goiter,
             Grave's disease), myxedema, or myxedema coma, even if treated.

          5. Patients currently receiving thyroid replacement therapy.

          6. Patients currently receiving Ketamine, levarterenol or dietary (non-food) iodine
             supplementation.

          7. Patients who have received any investigational drugs within the previous one month or
             five half-lives of the drug.

          8. Patients who are pregnant. Pregnancy testing will be done for women of child-bearing
             potential.

          9. Patients currently in atrial fibrillation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Irwin Klein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>North Shore University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2006</study_first_submitted>
  <study_first_submitted_qc>February 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2006</study_first_posted>
  <last_update_submitted>May 19, 2008</last_update_submitted>
  <last_update_submitted_qc>May 19, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 20, 2008</last_update_posted>
  <responsible_party>
    <name_title>Irwin Klein</name_title>
    <organization>North Shore University Hospital</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

